Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®

Drug Development and Industrial Pharmacy

Volumn 37, Issue 11, 2011, Pages 1365-1375

  Hoe, Susan ^a   Young, Paul M ^a   Traini, Daniela ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Carrier; Electrostatic charge; ENGI; Lactose; Salbutamol sulfate

Indexed keywords

ALPHA LACTOSE; DRUG CARRIER; SALBUTAMOL SULFATE;

AEROSOL; AIRFLOW; ARTICLE; DISPERSION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG RETENTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INHALER; MAGNITUDE ESTIMATION METHOD; PARTICLE SIZE; POWDER; STATIC ELECTRICITY; SURFACE PROPERTY; SUSPENSION;

ADMINISTRATION, INHALATION; ALBUTEROL; BRONCHODILATOR AGENTS; DRUG CARRIERS; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; STATIC ELECTRICITY;

EID: 80053994902     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.576679     Document Type: Article

References (26)

1. Zeng XM, Martin GP, Marriott C, Pritchard J. (2000). The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates. J Pharm Pharmacol, 52:1211-1221.
2. Young PM, Kwok P, Adi H, Chan HK, Traini D. (2009). Lactose composite carriers for respiratory delivery. Pharm Res, 26:802-810.
3. El-Sabawi D, Edge S, Price R, Young PM. (2006). Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: surface smoothing effects. Drug Dev Ind Pharm, 32:1135-1138. (Pubitemid 44721727)
4. Zeng XM, Martin GP, Marriott C, Pritchard J. (2001). Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J Pharm Sci, 90:1424-1434. (Pubitemid 32867990)
5. Saleem I, Smyth H, Telko M. (2008). Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics. Drug Dev Ind Pharm, 34:1002-1010.
6. Traini D, Young PM, Thielmann F, Acharya M. (2008). The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations. Drug Dev Ind Pharm, 34:992-1001.
7. Young PM, Sung A, Traini D, Kwok P, Chiou H, Chan HK. (2007). Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Pharm Res, 24:963-970. (Pubitemid 46680220)
8. Melandri C, Tarroni G, Prodi V, de Zaiacomo T, Formignani M, Lombardi CC. (1983). Deposition of charged particles in the human airways. J Aerosol Sci, 14:657-669. (Pubitemid 14192210)
9. Prodi V, Mularoni A. (1985). Electrostatic lung deposition experiments with humans and animals. Ann Occup Hyg, 29:229-240. (Pubitemid 15236802)
10. Murtomaa M, Pekkala P, Kalliohaka T, Paasi J. (2005) A device for aerosol charge measurement and sampling. J Electrostat, 63:571-575. (Pubitemid 40633801)
11. Chow KT, Zhu K, Tan RB, Heng PW. (2008). Investigation of electrostatic behavior of a lactose carrier for dry powder inhalers. Pharm Res, 25:2822-2834.
12. Byron PR, Peart J, Staniforth JN. (1997). Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers. Pharm Res, 14:698-705. (Pubitemid 27281661)
13. Glover W, Chan H-K. (2004). Electrostatic charge characterization of pharmaceutical aerosols using electrical low-pressure impactor (ELPI). J Aerosol Sci, 35:755-764. (Pubitemid 38668673)
14. Kwok PC, Glover W, Chan HK. (2005). Electrostatic charge characteristics of aerosols produced from metered dose inhalers. J Pharm Sci, 94:2789-2799. (Pubitemid 43273180)
15. Telko MJ, Kujanpää J, Hickey AJ. (2007). Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI). Int J Pharm, 336:352-360. (Pubitemid 46670665)
16. Kwok PC, Chan HK. (2008). Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols. Pharm Res, 25:277-288. (Pubitemid 351257975)
17. Hoe S, Young PM, Chan HK, Traini D. (2009). Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers. Pharm Res, 26:431-437.
18. Hoe S, Traini D, Chan HK, Young PM. (2009). The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers. Pharm Res, 26:2639-2646.
19. Hoe S, Traini D, Chan HK, Young PM. (2009). Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI). Eur J Pharm Sci, 38:88-94.
20. United States Pharmacopoeia (USP). Chapter 〈601〉, United States Pharmacopoeia 31 - National Formulary 26: United States Pharmacopoeial Convention Inc.; 2008.
21. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T et al. (2007). Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics. J Pharm Sci, 96:1302-1319. (Pubitemid 46804583)
22. Hoe S, Traini D, Chan HK, Young PM. (2010). The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems. Pharm Res, 27:1325-1336.
23. Zhu K, Ng WK, Shen S, Tan RB, Heng PW. (2008). Design of a device for simultaneous particle size and electrostatic charge measurement of inhalation drugs. Pharm Res, 25:2488-2496.
24. British Pharmacopoeia. (2009). Section 2.9.18 - Appendix XII C. Consistency of Formulated Preparations for inhalation.
25. Jones MD, Price R. (2006). The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm Res, 23:1665-1674. (Pubitemid 44200528)
26. Pilcer G, Amighi K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm, 392:1-19.